La cadena de opciones muestra datos clave de las opciones de acciones de Inhibikase Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Inhibikase Therapeutics..

Inhibikase Therapeutics (NASDAQ:IKT) Bolsa, Cadena de Opciones

INHIBIKASE THERAPEUTICS INC

Inhibikase Therapeutics

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Susquehanna analyst Charles Minervino maintains Howmet Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) with a Positive and raises the price target from $170 to $210.

News

Price Target

Analyst Ratings

Susquehanna Maintains Positive on Howmet Aerospace, Raises Price Target to $210

Wells Fargo analyst Chris Carey maintains Kraft Heinz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) with a Equal-Weight and raises the price target from $27 to $29.

Wells Fargo Maintains Equal-Weight on Kraft Heinz, Raises Price Target to $29

Wedbush analyst Michael Pachter reiterates Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Outperform and maintains $1400 price target.

Reiteration

NFLX

Wedbush Reiterates Outperform on Netflix, Maintains $1400 Price Target

Susquehanna analyst Charles Minervino maintains Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) with a Positive and raises the price target from $252 to $265.

Susquehanna Maintains Positive on Boeing, Raises Price Target to $265

XAIR

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Good Morning Traders! In today&#8217;s Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.
Our proprietary formula, exclusive to Market Clubhouse, dictates these price levels. This dynamic equation takes into account price, volume, and options flow. These levels are updated every day and shared with all Clubhouse Members, prior to the opening of the market.
We recommend closely monitoring these stocks, and be prepared to leverage potential breakouts or reversals. As always, stay alert and ready to adjust your tactics based on the market&#8217;s pulse to optimize your trading gains. Now, let&#8217;s dive into the stock analysis:
SPDR S&amp;P 500 ETF Trust (SPY)
SPY is presently trading near our important level of 621.68. Bulls are targeting an initial advance to 622.93. If momentum persists above 622.93, we anticipate buyers driving prices toward our next key support at 624.47. Should buyers confidently defend 624.47 throughout regular session trading, look for a continuation upward to 625.33, with our ultimate bullish target for the day sitting at 626.17.&nbsp;
If bulls lose their grip at 621.68, sellers will aim for downside momentum, initially challenging the 620.62 level. Continued bearish pressure will put the 619.33 mark at risk. Breaking this level decisively could see SPY quickly trading down toward the strong support at 617.59. If selling intensifies dramatically, bears might reach our lowest target for the session at 616.04.
Invesco QQQ Trust Series 1 (QQQ)
The QQQ is currently trading near our pivotal level of 552.58. Bulls must firmly establish price action above this mark, subsequently securing 554.51 as reliable intraday support. Persistent bullish sentiment should then encourage further upside momentum, targeting the next resistance at 556.99. If today&#8217;s buying is robust, anticipate a stretch toward 560.37, with our top bullish objective for the QQQ standing at 563.67.&nbsp;
Should QQQ fail to hold 552.58 convincingly during market hours, bears will seize control and push downward aggressively, first testing the 550.83 area. If weakness persists, expect a deeper selloff toward 549.69. Continued bearish dominance could trigger further downside pressure toward the support at 547.97. A breach here opens the door to our lowest bearish target of the day at 546.96.
Apple Inc. (AAPL)
Apple is trading near our crucial price level of 209.28. Bulls should aim to maintain this support, driving the stock upward initially toward 210.59. Sustained buying could elevate Apple to the next upside hurdle at 211.91. If bullish participants decisively dominate today&#8217;s trading, our high-end bullish target of 213.54 becomes attainable.&nbsp;
If buyers fail to defend the critical level at 209.28, bearish sellers will quickly target 208.28 as their first destination. Continuation of selling momentum would bring Apple down to the next support zone at 207.40. A breakdown of that level might induce additional selling toward 206.65, with further weakness potentially reaching our lower bear target at 206.02.
Microsoft Corp. (MSFT)
Microsoft is currently trading near our highlighted level of 500.77. Bulls will first need to secure the area above 500.47, setting the stage for a move upward toward 502.57, which would then act as an intraday support. Holding firmly above 502.57 would position Microsoft for a bullish run toward 504.44, with sustained buyer participation likely pushing prices to our daily bullish target of 506.88.&nbsp;
If 500.77 is not maintained, expect bears to swiftly challenge the 499.60 mark. Breaking below this support will encourage additional downside pressure, targeting 498.05. Should selling intensify, the next bearish objective becomes 496.53, ultimately opening a path toward our lowest bearish target for the session at 495.16.
NVIDIA Corporation (NVDA)
NVIDIA is currently trading around our critical level of 165.59. Bulls must push the price higher initially to reclaim and firmly establish support at 166.63. Continued upward momentum would then open a pathway to the next resistance point at 168.00. Strong buying throughout the day could drive NVIDIA further upward toward 169.34, with our top bullish target today placed at 171.00.&nbsp;
If NVIDIA cannot hold above 165.59, expect bearish sellers to target a move lower initially toward 163.39. A breakdown here with notable selling volume could rapidly take prices down to 161.88. Further weakening could see bears testing 160.57, and continued downside momentum might ultimately push NVIDIA toward our daily bearish objective at 159.58.
Alphabet Inc Class A (GOOGL)
Alphabet is presently trading close to our significant level of 179.08. Bulls will first aim to firmly secure this area as intraday support, targeting a push higher toward resistance at 180.13. Strong bullish activity might then extend this rally to reach today&#8217;s ultimate bullish target of 182.00.&nbsp;
If buyers are unable to protect 179.08, sellers will likely take control and aggressively test support lower at 177.97. If bearish sentiment intensifies, expect the auction to continue downward toward 176.86. Under heavy selling pressure, Alphabet could fall toward our low-end bearish objective of 175.13.
Meta Platforms Inc (META)
Meta is currently trading near our key level of 716.15. Bulls will look to establish firm price strength above 718.86, setting up the opportunity for further advances toward 720.81. Continued bullish conviction should then lift Meta toward the next resistance level at 723.45, with potential for buyers to drive price action toward our bullish target at 726.10.&nbsp;
If Meta fails to maintain support at 716.15, sellers will immediately target a decline to the support level at 712.24. Continued bearish activity would encourage a further drop toward 709.78. Should this area fail to hold, increased selling might accelerate the move down toward our lowest bearish target of the session at 707.78.
Tesla Inc. (TSLA)
Tesla is currently trading around our significant price level of 316.20. Bulls should first target a move upward to 318.48, with continued buying momentum potentially lifting prices to the next resistance at 322.16. If market sentiment is strongly bullish today, Tesla may push higher toward 328.09, with our maximum bullish objective sitting at 330.34.&nbsp;
If the support level at 316.20 is compromised, anticipate sellers moving swiftly to test lower prices around 314.36. Additional bearish pressure would likely bring Tesla down further to 312.52. Failure at this level with intensified selling could prompt further downside to our daily bearish target of 311.13.
Final Word: Today&#8217;s economic calendar is notably subdued, with minimal events on tap that could drive significant volatility. At 11:00 AM ET, the NY Fed&#8217;s 1-Year Inflation Expectations report will be released, providing a snapshot of consumer outlooks on future price pressures that might subtly influence bond yields or Fed policy expectations. Given the scarcity of major economic indicators, market participants should stay vigilant for any unforeseen news developments, such as corporate earnings surprises, geopolitical updates, or policy announcements, which could swiftly alter trading dynamics and sentiment.&nbsp;
Focus on disciplined risk management, including tight stops and balanced position sizing, to navigate potential headline-driven swings. Good luck out there, and trade with care and precision!
For a limited time during our special promotion, you can join RIPS and get a full access pass to Market Clubhouse for 7 full days for just $7. Check it out at <a href="https://marketclubhouse.club/7Days/" title="https://marketclubhouse.club/7Days/">https://marketclubhouse.club/7Days/</a> where you can trade live with him and tap into his wealth of knowledge and experience. You can also catch Rips on his live day trading streams every Monday-Friday at 8 am EST on the Market Clubhouse YouTube channel: <a href="https://www.youtube.com/@MarketClubhouse" title="https://www.youtube.com/@MarketClubhouse">https://www.youtube.com/@MarketClubhouse</a>.

Equities

Broad U.S. Equity ETFs

Technicals

Opinion

Signals

Tech

Trading Ideas

How To Trade Spy, Top Tech Stocks Using Technical Analysis

Wedbush analyst Laura Chico maintains Ultragenyx Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RARE#NASDAQ">RARE</a>) with a Neutral and lowers the price target from $35 to $34.

RARE

Wedbush Maintains Neutral on Ultragenyx Pharmaceutical, Lowers Price Target to $34

While artificial intelligence may dominate the digital sphere, this innovation wouldn't amount to much without specialized memory chips. That's where semiconductor giant Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) comes into view. True, Micron often doesn't get the frontline spotlight that enterprises like Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) effortlessly command. Still, the behind-the-scenes criticality of the business translates to plenty of attention for MU stock among knowledgeable traders.
Last month, Micron disclosed its financial results for the<a href="https://www.benzinga.com/markets/earnings/25/06/46104401/micron-q3-earnings-revenue-eps-beat-estimates-data-center-revenue-guidance-ai-demand"> third quarter of fiscal 2025</a>. In particular, the company reported revenue of $9.3 billion, beating the consensus estimate of $8.87 billion. On the bottom line, the semiconductor specialist reported adjusted earnings of $1.91 per share, exceeding the consensus view of $1.60.
Revenue was up roughly 16% against the year-ago quarter, benefiting from record demand in DRAM chips along with a nearly 50% sequential growth rate in high-bandwidth memory (HBM) sales. The latter product category is especially critical for accelerating AI processes. With no indication that enterprises are letting their foot off the gas regarding<a href="https://www.benzinga.com/content/46141316/micron-a-hot-buy-heats-up-fresh-all-time-highs-are-coming"> AI spending</a>, Micron potentially stands on viable ground.
It should also be noted that MU stock could potentially be receiving investor interest based on political dynamics. Thanks to the<a href="https://www.benzinga.com/news/politics/25/07/46263399/trump-says-us-will-raise-tariffs-to-up-to-70-as-july-9-deadline-looms"> tariff policies</a> of President Donald Trump, the memory market experienced a<a href="https://www.tomshardware.com/pc-components/dram/dram-prices-have-jumped-by-20-percent-for-the-second-month-in-a-row-surging-demand-is-likely-due-to-stockpiling"> surge</a> in demand earlier this year — a consequence of opportunistic transactions in front of incoming levies.
Still, not everything is aligned optimistically for MU stock. One of the biggest concerns about the memory chip industry is that it's a<a href="https://www.orbis.com/international/institutional/insights/memory-industry-cycles-not-the-business-cycle#:~:text=Memory%20chips%2C%20the%20short%2Dterm,fab%2C%20can%20cost%20%2415%20billion."> commoditized</a> business. These semiconductors are interchangeable and pricing may eventually collapse due to various factors, such as demand erosion or excess supply among competitors. Knowledgeable traders may recognize these trends and may seek to get ahead of them, potentially causing volatility.
Moreover, investors need to be cognizant of geopolitical risks. While Micron has been trimming its dependency on China, it's still<a href="https://www.cnbc.com/2023/10/23/micron-building-biggest-chip-fab-in-us-history-despite-china-ban.html"> exposed</a> to the world's second-largest economy. While the Trump administration has been<a href="https://www.benzinga.com/news/macro-notification/25/06/45876366/howard-lutnick-says-us-and-china-reached-a-framework-to-implement-geneva-consensus-following-trump-xi-call-csi-300-index-gains"> making progress regarding diplomatic and trade relations</a>, tensions are still relatively high. Therefore, a fracturing of this tenuous bond may present problems for MU stock.
The Direxion ETFs: With Micron caught in a sentiment tug-of-war, traders on both sides of the aisle have reason to consider Direxion's MU-focused exchange-traded funds. For optimistic speculators, the <a href="https://www.direxion.com/product/daily-mu-bull-and-bear-leveraged-single-stock-etfs?utm_source=Referral&amp;utm_medium=Text&amp;utm_source_platform=Benzinga&amp;utm_campaign=LandI_Product_MUU-MUD">Direxion Daily MU Bull 2X Shares</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MUU#NASDAQ">MUU</a>) seeks the daily investment results of 200% of the performance of MU stock. On the other hand, the <a href="https://www.direxion.com/product/daily-mu-bull-and-bear-leveraged-single-stock-etfs?utm_source=Referral&amp;utm_medium=Text&amp;utm_source_platform=Benzinga&amp;utm_campaign=LandI_Product_MUU-MUD">Direxion Daily Bear 1X Shares</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MUD#NASDAQ">MUD</a>) seeks 100% of the inverse performance of the namesake security.
In either case, the core attribute that drives these products is convenience. Typically, those seeking leveraged opportunities or participating in short positions must engage the options market. However, derivative financial products carry complexities that not all market participants may wish to accept. In contrast, Direxion ETFs can be bought and sold like any other publicly traded security, thereby mitigating the learning curve.
Nevertheless, these funds have certain risks to be aware of. Number one, leveraged and inverse ETFs tend to be more volatile than standard funds tracking the benchmark equities index. Number two, Direxion ETFs are designed for exposure lasting one trading session. Holding these products for longer than recommended may result in value decay due to the daily compounding phenomenon.
The MUU ETF: Since the start of the year, the MUU ETF has gained nearly 58% of value, magnifying the performance of MU stock.
<ul class="wp-block-list">
<li>A relatively new financial product, the MUU ETF has been on a rally since April, shooting the price action above its 20-day exponential moving average (on a weekly scale).</li>
<li>As impressive as its recent performance has been, the acceleration in the bull fund has slowed noticeably since mid-June, warranting a closer look.</li>
</ul>
<figure class="wp-block-image"><img loading="lazy" decoding="async" width="1001" height="626" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14085350/image-157.png" alt="" class="wp-image-983946" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14085350/image-157.png 1001w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14085350/image-157-300x188.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14085350/image-157-768x480.png 768w" sizes="(max-width: 1001px) 100vw, 1001px" /></figure>
The MUD ETF: From January's opening volley, the MUD ETF has struggled for traction, with the bear fund losing almost 45%,
<ul class="wp-block-list">
<li>In contrast to the bull fund, the MUD ETF is noticeably below its 20-day EMA (again, on a weekly scale), demonstrating persistent weakness.</li>
<li>It's notable that since late June, the bear fund appears to have stabilized, which may intrigue pessimistic speculators.</li>
</ul>
<figure class="wp-block-image"><img loading="lazy" decoding="async" width="1001" height="626" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14085350/image-157.png" alt="" class="wp-image-983947" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14085350/image-157.png 1001w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14085350/image-157-300x188.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14085350/image-157-768x480.png 768w" sizes="(max-width: 1001px) 100vw, 1001px" /></figure>
Featured image by <a href="https://pixabay.com/users/colossuscloud-2086276/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=1235959">Colossus Cloud</a> on <a href="https://pixabay.com/photos/server-cloud-development-business-1235959/">Pixabay</a>.

Long Ideas

Short Ideas

ETFs

NVDA

Direxion's Micron-Focused MUU, MUD ETFs Garner Attention Amid The AI Boom

WIIM

PTC shares are trading lower amid Autodesk's decision to drop its plans to acquire the company.

ADSK

Audodesk shares are trading higher amid the company's announcement to drop its plans to acquire PTC.

Susquehanna analyst Charles Minervino maintains ATI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) with a Positive and raises the price target from $73 to $105.

Susquehanna Maintains Positive on ATI, Raises Price Target to $105

Wedbush analyst Robert Driscoll initiates coverage on Crescent Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBIO#NASDAQ">CBIO</a>) with a Outperform rating and announces Price Target of $27.

Initiation

CBIO

Wedbush Initiates Coverage On Crescent Biopharma with Outperform Rating, Announces Price Target of $27

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer said Rocket Lab Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) is a buy, adding that it is &#8220;one of the hottest stocks in the universe.&#8221;
On June 30, the space-tech company notched its fastest launch turnaround ever, completing its 68th Electron mission and signaling a new era of rapid-response rocket deployment.
He also recommended buying Huntington Ingalls Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HII#NYSE">HII</a>).
Supporting his view, TD Cowen analyst Gautam Khanna, on July 10, upgraded Huntington Ingalls <a href="https://www.benzinga.com/quote/HII/analyst-ratings">from Hold to Buy and raised the price target from $250 to $300.</a>
&#8220;This thing is just a coiled spring when we get the new numbers,&#8221; Cramer said when asked about Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>). &#8220;There are many big studies coming down the pipe.&#8221;
Guggenheim analyst Seamus Fernandez, on July 11, maintained Eli Lilly with a Buy and raised the price target from $936 to $942.
When asked about TSS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>), he said, &#8220;That's a pretender. We want to be in CoreWeave if we're going to go there.&#8221;
On the earnings front, TSS, on May 15, reported a year-over-year increase in first-quarter revenue results.
Cramer recommended not buying Conagra Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>), saying it's a &#8220;very tough situation.&#8221;
The company, on July 10, reported adjusted earnings per share of 56 cents, missing the analyst consensus estimate of 58 cents. Quarterly net sales of $2.78 billion, missed the Street view of $2.83 billion.
Cramer recommended buying NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) on Monday morning.
Lending support to his choice, KeyBanc, on July 8, maintained an Overweight rating and raised the price target from $240 to $275.
Power Solutions International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIX#NASDAQ">PSIX</a>) is an &#8220;amazing stock, it's not even that expensive,&#8221; Cramer said.
Supporting his view, the company, on May 8, reported a year-over-year increase in first-quarter financial results.
Price Action:
<ul class="wp-block-list">
<li>Huntington Ingalls Industries shares gained 0.03% to settle at $258.18 on Friday.</li>
<li>Rocket Lab shares fell 0.2% to close at $39.03.</li>
<li>TSS shares gained 3.3% to settle at $26.46 on Friday.</li>
<li>Eli Lilly shares gained 0.3% to close at $793.01.</li>
<li>Conagra Brands shares fell 0.5% to settle at $19.40 on Friday.</li>
<li>NXP Semiconductors shares fell 1.8% to close at $228.92.</li>
<li>Power Solutions International shares gained 5.3% to settle at $72.02.</li>
</ul>
Read Next:<a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46364472/top-3-real-estate-stocks-that-may-fall-off-a-cliff-this-month"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46364472/top-3-real-estate-stocks-that-may-fall-off-a-cliff-this-month">Top 3 Real Estate Stocks That May Fall Off A Cliff This Month</a></li>
</ul>
Image: Shutterstock

SPACE

Markets

Media

NXPI

PSIX

RKLB

TSSI

This Is 'One Of The Hottest Stocks In The Universe,' Jim Cramer Says

As of July 14, 2025, two stocks in the utilities sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Kenon Holdings Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEN#NYSE">KEN</a>)</h3>
<ul class="wp-block-list">
<li>On May 28, Kenon Holdings announced its results for the first quarter and also additional updates. The company's stock jumped around 25% over the past month and has a 52-week high of $46.03.</li>
<li>RSI Value: 73.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>KEN Price Action: Shares of Kenon Holdings fell 1.1% to close at $44.91 on Friday.</li>
<li>Edge Stock Ratings: 92.53 Momentum score with Value at 71.16. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/ken"><img loading="lazy" decoding="async" width="423" height="176" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14071346/image-152.png" alt="" class="wp-image-983774" style="width:276px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14071346/image-152.png 423w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14071346/image-152-300x125.png 300w" sizes="(max-width: 423px) 100vw, 423px" /></a></figure>
<h3 class="wp-block-heading">ALLETE Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALE#NYSE">ALE</a>)</h3>
<ul class="wp-block-list">
<li>On July 11, ALLETE announced an agreement with Minnesota Department of Commerce to deliver immediate post-closing cost savings and substantial benefits for customers and communities. &#8220;We are steadfast in our commitment to providing excellent service to our customers, supporting our communities and meeting the policy goals of the State of Minnesota, and we are pleased to have reached an agreement that will deliver enhanced benefits for our customers, our employees and the communities we serve,&#8221; said ALLETE Chair, President and CEO Bethany Owen. The company's stock gained around 2% over the past five days and <a href="https://www.benzinga.com/quote/ALE">has a 52-week high</a> of $66.40.</li>
<li>RSI Value: 78.3</li>
<li>ALE Price Action: Shares of ALLETE gained 1.7% to close at $66.06 on Friday.</li>
</ul>
Don't miss out on the full BZ Edge Rankings—<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">compare all the key stocks now</a>.
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46364472/top-3-real-estate-stocks-that-may-fall-off-a-cliff-this-month">Top 3 Real Estate Stocks That May Fall Off A Cliff This Month</a></li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Top 2 Utilities Stocks That May Plunge This Quarter

Company's current total of approximately $500 million of ETH exceeds the initial $250 million PIPE proceeds by over 100%
BitMine's ETH holdings exceed 163,000
Company's Ethereum treasury strategy to strengthen broader Ethereum ecosystem
LAS VEGAS, July 14, 2025 /PRNewswire/ -- (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#NYSE">BMNR</a>) ("BitMine" or the "Company") today announced holdings of ETH exceeding $500 million. The Company closed on its initial private placement of $250 million on July 9th in furtherance of its asset light treasury strategy. As of July 14th at 7:45am ET, the company's ETH holdings total 163,142 at $3,072.67 per ETH (Bloomberg).
"Since closing on the $250 million private placement, we have surpassed $500 million in Ethereum holdings, which validates our mission to increase our stake in the Ethereum network," said Thomas "Tom" Lee of Fundstrat, the newly appointed Chairman of BitMine's Board of Directors.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

BMNR

BitMine's ETH Holdings Holds ~$500M With 163,142 ETH, Doubling Initial $250M PIPE Investment

Piper Sandler analyst Biren Amin maintains BridgeBio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) with a Overweight and raises the price target from $63 to $68.

BBIO

Piper Sandler Maintains Overweight on BridgeBio Pharma, Raises Price Target to $68

<a href="https://www.bloomberg.com/news/articles/2025-07-14/autodesk-is-said-to-drop-pursuit-of-software-firm-ptc?srnd=technology-ai" title="https://www.bloomberg.com/news/articles/2025-07-14/autodesk-is-said-to-drop-pursuit-of-software-firm-ptc?srnd=technology-ai">https://www.bloomberg.com/news/articles/2025-07-14/autodesk-is-said-to-drop-pursuit-of-software-firm-ptc?srnd=technology-ai</a>

Contracts

'Autodesk Drops Pursuit of Software Firm PTC' - Bloomberg News

Offerings

CTOR

Citius Oncology Files For $15M Offering

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Keybanc raised FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) price target from $53 to $61. Keybanc analyst Aleksey Yefremov maintained an Overweight rating. FMC shares closed at $42.38 on Friday. See how other analysts <a href="https://www.benzinga.com/quote/FMC/analyst-ratings">view this stock</a>.</li>
<li>Barclays boosted the price target for Charter Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) from $320 to $341. Barclays analyst Kannan Venkateshwar maintained an Underweight rating. Charter Communications shares closed at $392.20 on Friday. <a href="https://www.benzinga.com/quote/CHTR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel cut HubSpot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) price target from $750 to $700. Stifel analyst Parker Lane maintained a Buy rating. HubSpot shares closed at $524.27 on Friday. See how other analysts <a href="https://www.benzinga.com/quote/HUBS/analyst-ratings">view this stock</a>.</li>
<li>UBS boosted the price target for Visteon Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VC#NASDAQ">VC</a>) from $85 to $142. UBS analyst Joseph Spak upgraded the stock from Neutral to Buy. Visteon shares closed at $110.73 on Friday. <a href="https://www.benzinga.com/quote/VC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley raised the price target for CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) from $490 to $495. Morgan Stanley analyst Hamza Fodderwala downgraded the stock from Overweight to Equal-Weight. CrowdStrike shares closed at $478.45 on Friday. See how other analysts <a href="https://www.benzinga.com/quote/CRWD/analyst-ratings">view this stock</a>.</li>
<li>Piper Sandler raised Twilio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) price target from $121 to $140. Piper Sandler analyst James Fish maintained an Overweight rating. Twilio shares settled at $113.16 on Friday. <a href="https://www.benzinga.com/quote/TWLO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird increased Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) price target from $110 to $120. Baird analyst Colin Sebastian maintained an Outperform rating. Shopify shares closed at $112.11 on Friday. <a href="https://www.benzinga.com/quote/SHOP/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham raised Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) price target from $100 to $109. Needham analyst Bernie McTernan maintained a Buy rating. Uber shares closed at $95.39 on Friday.  <a href="https://www.benzinga.com/quote/UBER/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler cut the price target for Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) from $82 to $75. Piper Sandler analyst Peter Keith downgraded the stock from Overweight to Neutral. Best Buy shares settled at $71.79 on Friday. <a href="https://www.benzinga.com/quote/BBY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays increased Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) price target from $20 to $24. Barclays analyst Paul Kearney maintained an Overweight rating. Levi Strauss shares closed at $21.95 on Friday. <a href="https://www.benzinga.com/quote/levi/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying UBER stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/UBER/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="585" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14084233/image-156-1024x585.png" alt="" class="wp-image-983928" style="width:585px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14084233/image-156-1024x585.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14084233/image-156-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14084233/image-156-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14084233/image-156.png 1107w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46388321/top-3-health-care-stocks-that-could-blast-off-in-july">Top 3 Health Care Stocks That Could Blast Off In July</a></li>
</ul>
Photo via Shutterstock

CHTR

CRWD

HUBS

LEVI

SHOP

TWLO

UBER

Uber To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday

Macro Economic Events

Economics

Federal Reserve

Fed's Hammack Says We Are Pretty Close To Where The Neutral Rate Is; Doesn't See Imminent Need To Cut Rates; If Fed Sees Economy Weaken Of Course Fed Will Respond

Earnings

Health Care

Press Releases

Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity

General

Inhibikase Therapeutics Announces Pricing of $110 Million Private Placement to Advance IkT-001Pro, an Optimized Prodrug of Imatinib, into a Late-Stage Trial in Pulmonary Arterial Hypertension

Inhibikase Therapeutics Announces Closing of up to $275 Million Financing and Advancement of IkT-001Pro into a Late Stage Clinical Trial in Pulmonary Arterial Hypertension

Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity

Management

Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company's Growth

Inhibikase Announces Expansion of Senior Leadership Team

Inhibikase Therapeutics Announces 2024 Financial Results and Highlights Recent Activity

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Inhibikase Therapeutics, Inc. (NASDAQ: IKT)

Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity

Comments

Inhibikase Therapeutics

Inhibikase Therapeutics (IKT) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL